The US Food and Drug Administration (FDA) has approved a new dosing regimen for LEQEMBI, a treatment for early Alzheimer’s disease, according to Eisai and Biogen Inc. The maintenance dosing will now ...

Embracing these simple strategies to prioritise our brain health and wellbeing is essential for a happier and more fulfilling ...

GSK and the University of Oxford have entered a new research partnership to launch an immuno-prevention programme to explore ...

Mitochondria are crucial organelles for cellular homeostasis, regulating processes such as ATP production, reactive oxygen ...

There's a lot of evidence in animal models and humans that lifestyle interventions—we're not even talking about drugs—can have a dramatic effect on how long you're going to live,” says Eric Verdin, MD ...

A study examines how repeated head impacts can result in long-term brain injuries and explores potential treatments and ...

Glaucoma is a complex and multifactorial neurodegenerative disorder primarily characterized by the progressive loss of retinal ganglion cells (RGCs) and their axons, leading to irreversible visual ...

GSK plc and the University of Oxford (Oxford) announced that they have entered a new research collaboration focused on the potential of cancer prevention through vaccination. The GSK-Oxford Cancer ...

The Chinese study, published in the journal Nature Aging, measured levels in the brain of 13 proteins that are associated ...

Parkinson’s disease is a progressive neurodegenerative disorder that affects millions of people worldwide. In the United ...

Stop the Spread. Injecting saline into mouse kidneys did not affect the left or right substantia nigra (top). Injecting fibrils of α-synuclein ablated about half of the dopaminergic neurons (middle ...